semaglutide fda shortage Ozempic and Wegovy removed from the FDA's drug list Marti Law Group Files Amicus

Cardiometabolic risk intensification: Autoimmune type 1 diabetes has historically skewed toward leaner phenotypes

Now that GLP-1 agonists are a prominent treatment for overweight and obesity, researchers have begun looking at how patients with rheumatologic diseases respond to these products

The Verdict: This trial confirms that GHK-peptides are a clinically proven solution for increasing hair count and density without the side effects often associated with pharmaceutical hair loss products

A Washington State University investigation found that the lead author altered images in her dissertation and at least four co-authored papers from 2011-2014